Skip to main content
. 2021 Jul 9;8:678701. doi: 10.3389/fmolb.2021.678701

FIGURE 7.

FIGURE 7

Best-scoring pose from docking for (A) lapatinib, (B) imatinib, and (C) adapalene to the receptor binding domain of the spike protein (spike1 site). Panel (D) shows the best-scoring dock pose for candesartan cilexetil to Mpro. Labels identify protein residues neighboring the docked compounds.